Simultaneous Analysis of Irbesartan and Hydrochlorothiazide: An Improved HPLC Method with the Aid of a Chemometric Protocol
Open Access
- 16 March 2012
- Vol. 17 (3), 3461-3474
- https://doi.org/10.3390/molecules17033461
Abstract
Experimental design method was used for HPLC determination of irbesartan and hydrochlorothiazide in combined dosage forms. The traditional approach for optimization of experiments is time-consuming, involves a large number of runs and does not allow establishing the multiple interacting parameters. The main advantages of the experimental design method include the simultaneous screening of a larger number of factors affecting response and the estimation of possible interactions. On the basis of preliminary experiments, three factors-independent variables were selected as inputs (methanol content, pH of the mobile phase and temperature) and as dependent variables, five responses (resolution, symmetry of irbesartan peak, symmetry of hydrochlorothiazide peak, retention factor of irbesartan and retention factor of hydrochlorothiazide) were chosen. A full 23 factorial design, where factors were examined at two different levels (“low” and “high”) was used to determine which factors had an effect on the studied response. Afterwards, experimental design was used to optimize these influent parameters in the previously selected experimental domain. The novelty of our method lies in the optimization step accomplished by Derringer¢s desirability function. After optimizing the experimental conditions a separation was conducted on a Supelcosil C18 (150 mm × 4.6 mm, 5 mm particle size) column with a mobile phase consisting of methanol-tetrahydrofuran-acetate buffer 47:10:43 v/v/v, pH 6.5 and a column temperature of 25 °C. The developed method was successfully applied to the simultaneous separation of these drug-active compounds in their commercial pharmaceutical dosage forms.This publication has 16 references indexed in Scilit:
- RAPID SIMULTANEOUS DETERMINATION OF ALISKIREN AND HYDROCHLOROTHIAZIDE FROM THEIR PHARMACEUTICAL FORMULATIONS BY MONOLITHIC SILICA HPLC COLUMN EMPLOYING EXPERIMENTAL DESIGNSJournal of Liquid Chromatography & Related Technologies, 2011
- A validated stability indicating HPTLC method for simultaneous estimation of irbesartan and hydrochlorothiazidePharmaceutical Methods, 2010
- Combined effect of polarity and pH on the chromatographic behavior of some angiotensin II receptor antagonists and optimization of their determination in pharmaceutical dosage formsJournal of Pharmaceutical and Biomedical Analysis, 2010
- Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma using HPLC coupled with tandem mass spectrometry: Application to bioequivalence studiesJournal of Pharmaceutical and Biomedical Analysis, 2010
- A validated stability indicating HPTLC method for simultaneous estimation of irbesartan and hydrochlorothiazidePharmaceutical Methods, 2010
- Study of forced degradation behavior of Eletriptan hydrobromide by LC and LC–MS and development of stability-indicating methodJournal of Pharmaceutical and Biomedical Analysis, 2009
- Quantitative Analysis of Irbesartan in Pharmaceuticals and Human Biological Fluids by VoltammetryAnalytical Letters, 2009
- Development and validation of a HPTLC method for the simultaneous estimation of irbesartan and hydrochlorothiazide in tablet dosage formIndian Journal of Pharmaceutical Sciences, 2007
- MultiSimplex and experimental design as chemometric tools to optimize a SPE-HPLC-UV method for the determination of eprosartan in human plasma samplesTalanta, 2006
- Determination of hydrochlorothiazide in pharmaceutical formulations by diffuse reflectance spectroscopyEcletica Quimica, 2005